by Avi Kapoor | Mar 11, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Raymond James analyst Christopher Raymond initiated coverage on...
by Kaustubh Bagalkote | Mar 11, 2026 | General
Oracle Corp (NYSE:ORCL) is jumping in premarket trading Wednesday. Strong quarterly results and bold AI-driven guidance are driving the move. Oracle Smashes Q3 Revenue And Earnings Estimates Oracle reported third-quarter fiscal 2026 revenue of $17.19 billion. That...
by Avi Kapoor | Mar 11, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst Uy Ear upgraded Uniqure NV (NASDAQ:QURE) from...
by Avi Kapoor | Mar 11, 2026 | General
On CNBC’s “Halftime Report Final Trades,” Malcolm Ethridge, managing partner at Capital Area Planning Group, said it’s a great time to buy Spotify Technology S.A. (NYSE:SPOT) stock. Supporting his view, Spotify reported on Feb. 10 its fourth-quarter 2025...
by Vandana Singh | Mar 11, 2026 | General
Scienture Holdings, Inc. (NASDAQ:SCNX) on Wednesday formalized multiple commercial Group Purchasing Organization (GPO) agreements for Rezenopy (naloxone HCl) Nasal Spray 10 mg. Rezenopy, an opioid antagonist, received FDA approval in April 2024 for the emergency...
Recent Comments